Affordable Medicines Europe
EU Lobbying Profiles
Affordable Medicines Europe
Register: EU_TRANSPARENCY_REGISTER
Declared Spend (Max)
€599,999
Regulatory Meetings
Exchange of views on contribution of the independent distribution sector to strengthening competition, enhancing security of supply, and improving patients' access to affordable medicines across the EU
Exchange of views on MDR/IVDR revision proposal
All pressing portfolio topics
All pressing portfolio topics
All pressing portfolio topics
EU pharmaceutical regulation and policy
Parallel imports Pharmaceutical legislation
Simplification agenda and competitiveness
Revision of the Pharmaceutical Package
Upcoming revision of the EU pharmaceutical legislation; the critical point of the public service obligation proposed for manufacturers (Article 39(2)); the need for a European level public service obligation; the electronic patient leaflet;
Government Procurement
No government procurement contracts found.
Executive Insider Trades
No executive insider trades reported.